Related by context. Frequent words. (Click for all words.) 60 limiting toxicity 59 Welchol 58 dose limiting toxicities 57 Secondary endpoints include 57 evaluable patients 57 HGS ETR1 57 events AEs 56 secondary endpoint 56 INCB# [002] 56 free survival PFS 56 Secondary endpoints 56 vinorelbine 56 tolerated dose MTD 55 eculizumab 55 RECIST criteria 55 mg doses 55 Phase 2b study 54 Phase 2a clinical 54 creatinine clearance 54 mg BID 54 dose escalation trial 54 phase IIb 54 Phase 2a trial 54 Phase 2b trial 54 eltrombopag 54 evaluable 54 ACTEMRA 53 sustained virologic response 53 composite endpoint 53 LEVADEX 53 mitoxantrone 53 Phase IIa clinical 53 ofatumumab 53 bosentan 53 Secondary endpoints included 53 LymphoStat B 53 febrile neutropenia 53 vandetanib 53 Bronchitol 53 mg dose 53 CYPHER ® Stent 53 mg/m2 52 blinatumomab 52 placebo p = 52 tolerability 52 sunitinib 52 tiotropium 52 plus ribavirin 52 XGEVA 52 primary endpoint 52 Phase IIb clinical 52 Phase 1b 52 Zerenex 52 certolizumab pegol 52 Phase IIa trial 52 adalimumab 51 lubiprostone 51 treatment emergent adverse 51 Phase Ib 51 dimebon 51 liver metastases 51 RECIST 51 FOLFOX 51 FOLOTYN 51 efficacy endpoints 51 elagolix 51 peginterferon alfa 2a 51 pharmacodynamic 51 clinical endpoints 51 COPAXONE R 51 Phase 1b clinical 50 dose escalation 50 Azixa 50 chronic angina 50 ZYBRESTAT 50 peginterferon 50 rotigotine 50 primary efficacy endpoint 50 antitumor activity 50 tolerability profile 50 zoledronic acid 50 Prochymal 50 median PFS 50 TIMI 50 Phase 2b 50 non inferiority 49 telbivudine 49 panitumumab 49 secondary endpoints 49 proteinuria 49 multiple ascending dose 49 sorafenib 49 placebo p 49 unblinded 49 Phase III pivotal 49 sirolimus 49 blind randomized placebo 49 monotherapy 49 ticagrelor 49 abatacept 49 Phase 2b clinical